Cataract Trifocal intraocular lens Reviol Visual Outcomes Patient Satisfaction
Conditions
Interventions
Patients with cataract who were undergone phacoemulsification with bilateral trifocal intraocular lens implantation
Treatment
Sponsors
RX company Ltd and VSY Biotechnology
Eligibility
Sex/Gender
All
Age
40 Years to 85 Years
Inclusion criteria
Inclusion criteria: No other ocular diseases except cataract Corneal astigmatism less than 1 diopter Stable keratometric parameters in the last 12 months Patient with visually significant cataract who needs cataract surgery with desire to be spectacle independence for distance, intermediate, and far vision after cataract surgery.
Exclusion criteria
Exclusion criteria: Have other ocular diseases including retinal diseases, corneal diseases, optic nerve abnormalities, uveitis, and glaucoma Have previous ocular surgery Intraocular pressure more than 21 mm.Hg. Cataract patient who do not have stable capsular bag for intraocular lens implantation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual acuity at distance, intermediate and near 6 months after bilateral implantation of trifocal intraocular lens LogMAR | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction 6 months after bilateral implantation of trifocal intraocular lens questionnaire,Spherical equivalence 6 months after bilateral implantation of trifocal intraocular lens Diopter | — |
Countries
Thailand
Contacts
Public ContactVilavun Puangsricharern
Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University
Outcome results
None listed